Hypoxia-inducible factor (HIF) in human tumorigenesis - PubMed
- ️Invalid Date
Review
Hypoxia-inducible factor (HIF) in human tumorigenesis
N J Mabjeesh et al. Histol Histopathol. 2007 May.
Abstract
Hypoxia is a major event that occurs in most solid tumors. Intratumoral hypoxia is sufficient to activate the key transcription factor, hypoxia-inducible factor (HIF) that mediates the activation of the "survival machinery" in cancer cells. HIF can also be induced by oxygen-independent genetic alterations that activate a variety of oncogenic signaling pathways or inactivate tumor suppressors. Increased tumor HIF occurs at early stages of carcinogenesis and is often correlated with increased angiogenesis, malignant progression, poor patient prognosis and chemoradio-resistance. HIF-alpha subunit, the oxygen-regulated subunit of HIF is overexpressed in a wide range of human solid tumors. Nuclear HIF-alpha protein immunostaining was restricted to tumor cells compared to normal tissues. Herein, we review and discuss the role of HIF in tumorigenesis and describe the overexpression of HIF-alpha proteins in human cancers and its association with overall clinical outcomes.
Similar articles
-
HIF-1 and tumor progression: pathophysiology and therapeutics.
Semenza GL. Semenza GL. Trends Mol Med. 2002;8(4 Suppl):S62-7. doi: 10.1016/s1471-4914(02)02317-1. Trends Mol Med. 2002. PMID: 11927290 Review.
-
Role of hypoxia-inducible factor-1alpha as a cancer therapy target.
Patiar S, Harris AL. Patiar S, et al. Endocr Relat Cancer. 2006 Dec;13 Suppl 1:S61-75. doi: 10.1677/erc.1.01290. Endocr Relat Cancer. 2006. PMID: 17259560 Review.
-
The role of hypoxia-inducible factors in tumorigenesis.
Rankin EB, Giaccia AJ. Rankin EB, et al. Cell Death Differ. 2008 Apr;15(4):678-85. doi: 10.1038/cdd.2008.21. Epub 2008 Feb 15. Cell Death Differ. 2008. PMID: 18259193 Free PMC article. Review.
-
Oncological implications of hypoxia inducible factor-1alpha (HIF-1alpha) expression.
O'Donnell JL, Joyce MR, Shannon AM, Harmey J, Geraghty J, Bouchier-Hayes D. O'Donnell JL, et al. Cancer Treat Rev. 2006 Oct;32(6):407-16. doi: 10.1016/j.ctrv.2006.05.003. Epub 2006 Aug 4. Cancer Treat Rev. 2006. PMID: 16889900 Review.
-
Garayoa M, Martínez A, Lee S, Pío R, An WG, Neckers L, Trepel J, Montuenga LM, Ryan H, Johnson R, Gassmann M, Cuttitta F. Garayoa M, et al. Mol Endocrinol. 2000 Jun;14(6):848-62. doi: 10.1210/mend.14.6.0473. Mol Endocrinol. 2000. PMID: 10847587
Cited by
-
Hypoxia, cancer metabolism and the therapeutic benefit of targeting lactate/H(+) symporters.
Marchiq I, Pouysségur J. Marchiq I, et al. J Mol Med (Berl). 2016 Feb;94(2):155-71. doi: 10.1007/s00109-015-1307-x. Epub 2015 Jun 24. J Mol Med (Berl). 2016. PMID: 26099350 Free PMC article. Review.
-
Valavanidis A, Vlachogianni T, Fiotakis K, Loridas S. Valavanidis A, et al. Int J Environ Res Public Health. 2013 Aug 27;10(9):3886-907. doi: 10.3390/ijerph10093886. Int J Environ Res Public Health. 2013. PMID: 23985773 Free PMC article. Review.
-
HIF induces human embryonic stem cell markers in cancer cells.
Mathieu J, Zhang Z, Zhou W, Wang AJ, Heddleston JM, Pinna CM, Hubaud A, Stadler B, Choi M, Bar M, Tewari M, Liu A, Vessella R, Rostomily R, Born D, Horwitz M, Ware C, Blau CA, Cleary MA, Rich JN, Ruohola-Baker H. Mathieu J, et al. Cancer Res. 2011 Jul 1;71(13):4640-52. doi: 10.1158/0008-5472.CAN-10-3320. Epub 2011 Jun 28. Cancer Res. 2011. PMID: 21712410 Free PMC article.
-
High SEPT9_i1 protein expression is associated with high-grade prostate cancers.
Gilad R, Meir K, Stein I, German L, Pikarsky E, Mabjeesh NJ. Gilad R, et al. PLoS One. 2015 Apr 21;10(4):e0124251. doi: 10.1371/journal.pone.0124251. eCollection 2015. PLoS One. 2015. PMID: 25898316 Free PMC article.
-
Expression of MDR1, HIF-1α and MRP1 in sacral chordoma and chordoma cell line CM-319.
Ji Z, Long H, Hu Y, Qiu X, Chen X, Li Z, Fan D, Ma B, Fan Q. Ji Z, et al. J Exp Clin Cancer Res. 2010 Dec 8;29(1):158. doi: 10.1186/1756-9966-29-158. J Exp Clin Cancer Res. 2010. PMID: 21143841 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources